Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Patients dropped fewer pounds during real-world use compared to the amount lost in clinical trials A new study analyzed ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

A new study looked at the effect of semaglutide vs. tirzepatide on weight loss over a 72 week period. At the end of the 72 ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

ABC News' Dr. Tara Narula explains a new study indicating that stopping GLP 1 weight loss medications too soon could make it harder to lose weight.

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

A study from Mass General Brigham and Harvard Medical School raises questions about a new class of weight loss drugs — and ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...